Lv41
770 积分 2024-01-02 加入
Improvement in Patient-Reported Visual Function After Ocriplasmin for Vitreomacular Adhesion: Results of the Microplasmin for Intravitreous Injection-Traction Release Without Surgical Treatment (MIVI-TRUST) Trials
6天前
已完结
Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion/traction
6天前
已完结
Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study
6天前
已完结
Retinal detachment after intravitreal ocriplasmin injection
6天前
已完结
Safety of intravitreal ocriplasmin for focal vitreomacular adhesion in patients with exudative age-related macular degeneration
6天前
已完结
Ocriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular hole. First clinical experiences
6天前
已完结
Autolytic degradation of ocriplasmin: a complex mechanism unraveled by mutational analysis
6天前
已完结
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes
6天前
已完结
OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study
6天前
已完结
Safety of intravitreal ocriplasmin for focal vitreomacular adhesion in patients with exudative age-related macular degeneration
6天前
已完结
皖公网安备34019202002308
